Share this
Bristol Myers Squibb to Acquire Turning Point Therapeutics for $4.1 Billion
General Catalyst Leads Eleanor Health’s $50 Million Series C
Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II
Baylis Medical Agrees to Sell to Boston Scientific for $1.75 Billion
Flexion Therapeutics Agrees to Sell to Pacira BioSciences
Warby Parker – Direct Listing
ZOLL Medical Agrees to Acquire Itamar Medical for $538 Million
Lyell Immunopharma – $425 Million IPO
Olive Closes $225 Million Financing, Acquires Verata Health
Opthea – $128 Million IPO
ArcherDX Agrees to Combine With Invitae in $2.7 Billion Deal
Orca Bio Raises $192 Million Series D to Transform Allogenic Cell Therapy
Avidity Biosciences - $289 Million IPO
Vaxcyte - $288 Million IPO
Reata Pharmaceuticals – $505 Million Follow-On Offering
argenx – $557 Million Follow-On Offering